- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Hybio Pharmaceutical (300199)
Hybio Pharmaceutical stock price live, this page displays SZ 300199 stock exchange data. View the 300199 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Hybio Pharmaceutical real time stock price chart below.
What Is the Hybio Pharmaceutical Stock Price Today?
The Hybio Pharmaceutical stock price today is 20.20.
What Is the Stock Symbol for Hybio Pharmaceutical?
The stock symbol for Hybio Pharmaceutical is "300199."
What Stock Exchange Does Hybio Pharmaceutical Trade On?
Hybio Pharmaceutical is listed and trades on the Shenzhen stock exchange.
Is Hybio Pharmaceutical a Good Stock to Buy?
Determining whether Hybio Pharmaceutical—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 300199 quote. (ISIN: CNE1000011T7)
What Is the Hybio Pharmaceutical Stock Price Today?
The Hybio Pharmaceutical stock price today is 20.20.
What Is the Stock Symbol for Hybio Pharmaceutical?
The stock symbol for Hybio Pharmaceutical is "300199."
What Stock Exchange Does Hybio Pharmaceutical Trade On?
Hybio Pharmaceutical is listed and trades on the Shenzhen stock exchange.
Is Hybio Pharmaceutical a Good Stock to Buy?
Determining whether Hybio Pharmaceutical—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 300199 quote. (ISIN: CNE1000011T7)
Shenzhen
Currency in CNY
20.20
-0.44(-2.13%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
20.03
21.30
52 wk Range
16.23
31.19
300199 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
20.0321.30
52 wk Range
16.2331.19
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
300199 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Earnings
Latest Release
Apr 28, 2026
EPS / Forecast
0.14 / --
Revenue / Forecast
299.15M / --
Compare 300199 to Peers and Sector
Metrics to compare | 300199 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship300199PeersSector | |
|---|---|---|---|---|
P/E Ratio | 192.9x | −4.9x | −0.3x | |
PEG Ratio | 0.94 | 0.05 | 0.00 | |
Price/Book | 24.6x | 2.0x | 2.6x | |
Price / LTM Sales | 19.1x | 4.0x | 2.9x | |
Upside (Analyst Target) | - | 67.3% | 56.7% | |
Fair Value Upside | Unlock | 1.9% | 10.2% | Unlock |
Hybio Pharmaceutical Co., Ltd. engages in the research, development, production, and marketing of pharmaceutical products in China and internationally. The company offers finished dosage form (FDF) products for obstetrics and gynecology, haemostatic agent, digestive tract and metabolic systems, immune system modulation, cardiovascular, diabetes mellitus, and osteoporosis, as well as medical devices comprising disposable injectable pens; and peptide active pharmaceutical ingredients (API) comprising polypeptides, small molecules and nucleic acids, and intermediates for endocrine, nutritional, and metabolic diseases; digestive system diseases; neoplasms; nervous system diseases; pregnancy, childbirth, and puerperium; musculoskeletal system and connective tissue diseases; infectious and parasitic diseases; circulatory system diseases; blood and hematopoietic organ diseases; mental and behavioral disorders; tumor; urogenital system diseases; and genitourinary system diseases, as well as factors influencing health status. It also provides contract research, development, and manufacturing organization (CRDMO) services for peptide APIs, peptide formulations, oligonucleotide drugs, and pharmaceutical intermediates. In addition, the company engages in the provision of property services, technical services, technology development, technical consulting, technical exchange, technology transfer, and technology promotion, as well as non-residential real estate leasing. Hybio Pharmaceutical Co., Ltd. was founded in 1998 and is headquartered in Wuhan, China.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Hybio Pharmaceutical (300199) Stock Price Today?
The Hybio Pharmaceutical stock price today is 20.20 CNY.
What Stock Exchange Does Hybio Pharmaceutical Trade On?
Hybio Pharmaceutical is listed and trades on the Shenzhen Stock Exchange.
What Is the Stock Symbol for Hybio Pharmaceutical?
The stock symbol for Hybio Pharmaceutical is "300199."
What Is the Hybio Pharmaceutical Market Cap?
As of today, Hybio Pharmaceutical market cap is 17.84B CNY.
What Is Hybio Pharmaceutical's Earnings Per Share (TTM)?
The Hybio Pharmaceutical EPS (TTM) is 0.10.
When Is the Next Hybio Pharmaceutical Earnings Date?
Hybio Pharmaceutical will release its next earnings report on Aug 21, 2026.
From a Technical Analysis Perspective, Is 300199 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Hybio Pharmaceutical Stock Split?
Hybio Pharmaceutical has split 3 times.
How Many Employees Does Hybio Pharmaceutical Have?
Hybio Pharmaceutical has 1226 employees.
What is the current trading status of Hybio Pharmaceutical (300199)?
As of Jul 30, 2026, Hybio Pharmaceutical (300199) is trading at a price of 20.20 CNY, with a previous close of 20.64 CNY. The stock has fluctuated within a day range of 20.03 CNY to 21.30 CNY, while its 52-week range spans from 16.23 CNY to 31.19 CNY.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.